| Females | Males | ||
---|---|---|---|---|
Clinical cohort | Absolute change | Percent change | Absolute change | Percent change |
CPM trial 1 (pre surgery) | 8.56 (11.39) | 34.1% | 8.86 (12.04) | 18.9% |
CPM trial 2 (pre surgery) | 3.94 (7.80) | 21.1% | 5.06 (8.47) | 23.8% |
CPM trial 1 (3Â months) | 4.97 (9.22) | 40.3% | 7.04 (9.37) | 35.6% |
CPM trial 2 (3Â months) | 2.72 (7.77) | 1.2% | 4.69 (10.70) | 12.3% |
Healthy cohort | ||||
CPM trial 1 (day 1) | 9.11 (11.56) | 44.7% | 8.96 (11.50) | 54.0% |
CPM trial 2 (day 1) | 7.42 (11.98) | 41.5% | 6.55 (7.10) | 54.0% |
CPM trial 1 (day 3) | 10.05 (13.87) | 50.9% | 7.62 (10.67) | 39.6% |
CPM trial 2 (day 3) | 8.11 (13.13) | 41.9% | 5.27 (6.61) | 39.7% |
CPM trial 1 (day 5) | 9.87 (14.81) | 37.8% | 6.66 (10.67) | 47.8% |
CPM trial 1 (day 5) | 6.57 (10.17) | 38.6% | 5.81 (9.77) | 41.2% |